<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36651103</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1096-9896</ISSN><JournalIssue CitedMedium="Internet"><Volume>259</Volume><Issue>3</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>The Journal of pathology</Title><ISOAbbreviation>J Pathol</ISOAbbreviation></Journal><ArticleTitle>Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19.</ArticleTitle><Pagination><StartPage>254</StartPage><EndPage>263</EndPage><MedlinePgn>254-263</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/path.6035</ELocationID><Abstract><AbstractText>SARS-CoV-2 infection is clinically heterogeneous, ranging from asymptomatic to deadly. A few patients with COVID-19 appear to recover from acute viral infection but nevertheless progress in their disease and eventually die, despite persistent negativity at molecular tests for SARS-CoV-2 RNA. Here, we performed post-mortem analyses in 27 consecutive patients who had apparently recovered from COVID-19 but had progressively worsened in their clinical conditions despite repeated viral negativity in nasopharyngeal swabs or bronchioalveolar lavage for 11-300 consecutive days (average: 105.5&#x2009;days). Three of these patients remained PCR-negative for over 9&#xa0;months. Post-mortem analysis revealed evidence of diffuse or focal interstitial pneumonia in 23/27 (81%) patients, accompanied by extensive fibrotic substitution in 13 cases (47%). Despite apparent virological remission, lung pathology was similar to that observed in acute COVID-19 individuals, including micro- and macro-vascular thrombosis (67% of cases), vasculitis (24%), squamous metaplasia of the respiratory epithelium (30%), frequent cytological abnormalities and syncytia (67%), and the presence of dysmorphic features in the bronchial cartilage (44%). Consistent with molecular test negativity, SARS-CoV-2 antigens were not detected in the respiratory epithelium. In contrast, antibodies against both spike and nucleocapsid revealed the frequent (70%) infection of bronchial cartilage chondrocytes and para-bronchial gland epithelial cells. In a few patients (19%), we also detected positivity in vascular pericytes and endothelial cells. Quantitative RT-PCR amplification in tissue lysates confirmed the presence of viral RNA. Together, these findings indicate that SARS-CoV-2 infection can persist significantly longer than suggested by standard PCR-negative tests, with specific infection of specific cell types in the lung. Whether these persistently infected cells also play a pathogenic role in long COVID remains to be addressed. &#xa9; 2023 The Authors. The Journal of Pathology published by John Wiley &amp; Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. The Journal of Pathology published by John Wiley &amp; Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Bussani</LastName><ForeName>Rossana</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zentilin</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Correa</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colliva</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Silvestri</LastName><ForeName>Furio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zacchigna</LastName><ForeName>Serena</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Collesi</LastName><ForeName>Chiara</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Giacca</LastName><ForeName>Mauro</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2927-7225</Identifier><AffiliationInfo><Affiliation>Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Cardiovascular Medicine &amp; Sciences, King's College London, British Heart Foundation Centre of Research Excellence, London, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>787971</GrantID><Acronym>ERC_</Acronym><Agency>European Research Council</Agency><Country>International</Country></Grant><Grant><GrantID>RG/19/11/34633</GrantID><Acronym>BHF_</Acronym><Agency>British Heart Foundation</Agency><Country>United Kingdom</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Pathol</MedlineTA><NlmUniqueID>0204634</NlmUniqueID><ISSNLinking>0022-3417</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D042783" MajorTopicYN="N">Endothelial Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">cartilage</Keyword><Keyword MajorTopicYN="N">nucleocapsid</Keyword><Keyword MajorTopicYN="N">parabronchial glands</Keyword><Keyword MajorTopicYN="N">post-mortem analysis</Keyword><Keyword MajorTopicYN="N">spike</Keyword><Keyword MajorTopicYN="N">syncytia</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>18</Day><Hour>3</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36651103</ArticleId><ArticleId IdType="pmc">PMC10107739</ArticleId><ArticleId IdType="doi">10.1002/path.6035</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID&#x2010;19) outbreak in China: summary of a report of 72&#x2009;314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020; 323: 1239&#x2013;1242.</Citation><ArticleIdList><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Inciardi RM, Adamo M, Lupi L, et al. Characteristics and outcomes of patients hospitalized for COVID&#x2010;19 and cardiac disease in Northern Italy. Eur Heart J 2020; 41: 1821&#x2013;1829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239204</ArticleId><ArticleId IdType="pubmed">32383763</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID&#x2010;19 in the New York City area. JAMA 2020; 323: 2052&#x2013;2059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R, Schneider E, Zentilin L, et al. Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID&#x2010;19 pathology. EBioMedicine 2020; 61: 103104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7677597</ArticleId><ArticleId IdType="pubmed">33158808</ArticleId></ArticleIdList></Reference><Reference><Citation>Braga L, Ali H, Secco I, et al. Drugs that inhibit TMEM16 proteins block SARS&#x2010;CoV&#x2010;2 spike&#x2010;induced syncytia. Nature 2021; 594: 88&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611055</ArticleId><ArticleId IdType="pubmed">33827113</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz A, Bujnowski D, McMullen P, et al. Pulmonary parenchymal changes in COVID&#x2010;19 survivors. Ann Thorac Surg 2022; 114: 301&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8325553</ArticleId><ArticleId IdType="pubmed">34343471</ArticleId></ArticleIdList></Reference><Reference><Citation>Honigsbaum M, Krishnan L. Taking pandemic sequelae seriously: from the Russian influenza to COVID&#x2010;19 long&#x2010;haulers. Lancet 2020; 396: 1389&#x2013;1391.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7550169</ArticleId><ArticleId IdType="pubmed">33058777</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, et al. Persistent symptoms in patients after acute COVID&#x2010;19. JAMA 2020; 324: 603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID&#x2010;19 &#x201c;long haulers&#x201d; stump experts. JAMA 2020; 324: 1381&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Weerahandi H, Hochman KA, Simon E, et al. Post&#x2010;discharge health status and symptoms in patients with severe COVID&#x2010;19. J Gen Intern Med 2021; 36: 738&#x2013;745.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808113</ArticleId><ArticleId IdType="pubmed">33443703</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Monteil VM, Maurer&#x2010;Stroh S, et al. Monoclonal antibodies for the S2 subunit of spike of SARS&#x2010;CoV&#x2010;1 cross&#x2010;react with the newly&#x2010;emerged SARS&#x2010;CoV&#x2010;2. Euro Surveill 2020; 25: 2000291.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7376845</ArticleId><ArticleId IdType="pubmed">32700671</ArticleId></ArticleIdList></Reference><Reference><Citation>Szabolcs M, Sauter JL, Frosina D, et al. Identification of immunohistochemical reagents for in situ protein expression analysis of coronavirus&#x2010;associated changes in human tissues. Appl Immunohistochem Mol Morphol 2021; 29: 5&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7713639</ArticleId><ArticleId IdType="pubmed">33086222</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauter JL, Baine MK, Butnor KJ, et al. Insights into pathogenesis of fatal COVID&#x2010;19 pneumonia from histopathology with immunohistochemical and viral RNA studies. Histopathology 2020; 77: 915&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361244</ArticleId><ArticleId IdType="pubmed">32614086</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019&#x2010;nCoV) by real&#x2010;time RT&#x2010;PCR. Euro Surveill 2020; 25: 2000045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>Lax SF, Skok K, Zechner P, et al. Pulmonary arterial thrombosis in COVID&#x2010;19 with fatal outcome: results from a prospective, single&#x2010;center, clinicopathologic case series. Ann Intern Med 2020; 173: 350&#x2013;361.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7249507</ArticleId><ArticleId IdType="pubmed">32422076</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong X, Chi J, Gao Q. Prevalence and risk factors of thrombotic events on patients with COVID&#x2010;19: a systematic review and meta&#x2010;analysis. Thromb J 2021; 19: 32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8132033</ArticleId><ArticleId IdType="pubmed">34011381</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenner WJ, Gorog DA. Incidence of thrombotic complications in COVID&#x2010;19: on behalf of ICODE: the International COVID&#x2010;19 Thrombosis Biomarkers Colloquium. J Thromb Thrombolysis 2021; 52: 999&#x2013;1006.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8161345</ArticleId><ArticleId IdType="pubmed">34047938</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Yan X, Fan Q, et al. D&#x2010;dimer levels on admission to predict in&#x2010;hospital mortality in patients with Covid&#x2010;19. J Thromb Haemost 2020; 18: 1324&#x2013;1329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264730</ArticleId><ArticleId IdType="pubmed">32306492</ArticleId></ArticleIdList></Reference><Reference><Citation>Lippi G, Favaloro EJ. D&#x2010;dimer is associated with severity of coronavirus disease 2019: a pooled analysis. Thromb Haemost 2020; 120: 876&#x2013;878.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295300</ArticleId><ArticleId IdType="pubmed">32246450</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhary R, Garg J, Houghton DE, et al. Thromboinflammatory biomarkers in COVID&#x2010;19: systematic review and meta&#x2010;analysis of 17,052 patients. Mayo Clin Proc Innov Qual Outcomes 2021; 5: 388&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869679</ArticleId><ArticleId IdType="pubmed">33585800</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID&#x2010;19. Lancet 2020; 395: 1417&#x2013;1418.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ackermann M, Verleden SE, Kuehnel M, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in Covid&#x2010;19. N Engl J Med 2020; 383: 120&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7412750</ArticleId><ArticleId IdType="pubmed">32437596</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacca M, Shah AM. The pathological maelstrom of COVID&#x2010;19 and cardiovascular disease. Nat Cardiovasc Res 2022; 1: 200&#x2013;210.</Citation><ArticleIdList><ArticleId IdType="pubmed">39195986</ArticleId></ArticleIdList></Reference><Reference><Citation>Schaefer IM, Padera RF, Solomon IH, et al. In situ detection of SARS&#x2010;CoV&#x2010;2 in lungs and airways of patients with COVID&#x2010;19. Mod Pathol 2020; 33: 2104&#x2013;2114.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304376</ArticleId><ArticleId IdType="pubmed">32561849</ArticleId></ArticleIdList></Reference><Reference><Citation>Skok K, Stelzl E, Trauner M, et al. Post&#x2010;mortem viral dynamics and tropism in COVID&#x2010;19 patients in correlation with organ damage. Virchows Arch 2021; 478: 343&#x2013;353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438212</ArticleId><ArticleId IdType="pubmed">32815036</ArticleId></ArticleIdList></Reference><Reference><Citation>De Cock KM, Zielinski&#x2010;Guti&#xe9;rrez E, Lucas SB. Learning from the dead. N Engl J Med 2019; 381: 1889&#x2013;1891.</Citation><ArticleIdList><ArticleId IdType="pubmed">31722148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessa F, Salerno M, Pomara C. Autopsy tool in unknown diseases: the experience with coronaviruses (SARS&#x2010;CoV, MERS&#x2010;CoV, SARS&#x2010;CoV&#x2010;2). Medicina (Kaunas) 2021; 57: 309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064502</ArticleId><ArticleId IdType="pubmed">33806100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sessa F, Bertozzi G, Cipolloni L, et al. Clinical&#x2010;forensic autopsy findings to defeat COVID&#x2010;19 disease: a literature review. J Clin Med 2020; 9: 2026.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409028</ArticleId><ArticleId IdType="pubmed">32605192</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullard J, Dust K, Funk D, et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis 2020; 71: 2663&#x2013;2666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314198</ArticleId><ArticleId IdType="pubmed">32442256</ArticleId></ArticleIdList></Reference><Reference><Citation>Owusu D, Pomeroy MA, Lewis NM, et al. Persistent SARS&#x2010;CoV&#x2010;2 RNA shedding without evidence of infectiousness: a cohort study of individuals with COVID&#x2010;19. J Infect Dis 2021; 224: 1362&#x2013;1371.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989388</ArticleId><ArticleId IdType="pubmed">33649773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee PH, Tay WC, Sutjipto S, et al. Associations of viral ribonucleic acid (RNA) shedding patterns with clinical illness and immune responses in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS&#x2010;CoV&#x2010;2) infection. Clin Transl Immunology 2020; 9: e1160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385430</ArticleId><ArticleId IdType="pubmed">32742654</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemke G. How macrophages deal with death. Nat Rev Immunol 2019; 19: 539&#x2013;549.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6733267</ArticleId><ArticleId IdType="pubmed">31019284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H, Kim A, David T, et al. TMEM16F forms a Ca2+&#x2010;activated cation channel required for lipid scrambling in platelets during blood coagulation. Cell 2012; 151: 111&#x2013;122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3582364</ArticleId><ArticleId IdType="pubmed">23021219</ArticleId></ArticleIdList></Reference><Reference><Citation>Baig AA, Haining EJ, Geuss E, et al. TMEM16F&#x2010;mediated platelet membrane phospholipid scrambling is critical for hemostasis and thrombosis but not thromboinflammation in mice &#x2013; brief report. Arterioscler Thromb Vasc Biol 2016; 36: 2152&#x2013;2157.</Citation><ArticleIdList><ArticleId IdType="pubmed">27634832</ArticleId></ArticleIdList></Reference><Reference><Citation>Lhermusier T, Chap H, Payrastre B. Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost 2011; 9: 1883&#x2013;1891.</Citation><ArticleIdList><ArticleId IdType="pubmed">21958383</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Zheng Y, Niu Z, et al. SARS&#x2010;CoV&#x2010;2 spike protein dictates syncytium&#x2010;mediated lymphocyte elimination. Cell Death Differ 2021; 28: 2765&#x2013;2777.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056997</ArticleId><ArticleId IdType="pubmed">33879858</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long covid: how to define it and how to manage it. BMJ 2020; 370: m3489.</Citation><ArticleIdList><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg P, Arora U, Kumar A, et al. The &#x201c;post&#x2010;COVID&#x201d; syndrome: how deep is the damage? J Med Virol 2021; 93: 673&#x2013;674.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461449</ArticleId><ArticleId IdType="pubmed">32852801</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Knight M, A'Court C, et al. Management of post&#x2010;acute covid&#x2010;19 in primary care. BMJ 2020; 370: m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV. Long COVID&#x2010;19: challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr 2021; 15: 145&#x2013;146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737559</ArticleId><ArticleId IdType="pubmed">33341598</ArticleId></ArticleIdList></Reference><Reference><Citation>Tay MZ, Poh CM, R&#xe9;nia L, et al. The trinity of COVID&#x2010;19: immunity, inflammation and intervention. Nat Rev Immunol 2020; 20: 363&#x2013;374.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7187672</ArticleId><ArticleId IdType="pubmed">32346093</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceulemans LJ, Khan M, Yoo SJ, et al. Persistence of SARS&#x2010;CoV&#x2010;2 RNA in lung tissue after mild COVID&#x2010;19. Lancet Respir Med 2021; 9: e78&#x2013;e79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189667</ArticleId><ArticleId IdType="pubmed">34118186</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaul DR, Valesano AL, Petrie JG, et al. Donor to recipient transmission of SARS&#x2010;CoV&#x2010;2 by lung transplantation despite negative donor upper respiratory tract testing. Am J Transplant 2021; 21: 2885&#x2013;2889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014875</ArticleId><ArticleId IdType="pubmed">33565705</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>